These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16732764)

  • 21. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
    Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
    Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
    Shimshoni JA; Yagen B; Pessah N; Wlodarczyk B; Finnell RH; Bialer M
    Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic changes in gene expression profiles of 22q11 and related orthologous genes during mouse development.
    Amati F; Biancolella M; Farcomeni A; Giallonardi S; Bueno S; Minella D; Vecchione L; Chillemi G; Desideri A; Novelli G
    Gene; 2007 Apr; 391(1-2):91-102. PubMed ID: 17321697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M; Shirota M; Nagao T
    Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teratology study of derivatives of tetramethylcyclopropyl amide analogues of valproic acid in mice.
    Okada A; Onishi Y; Aoki Y; Yagen B; Sobol E; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2006 Jun; 77(3):227-33. PubMed ID: 16767757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
    Bojic U; Elmazar MM; Hauck RS; Nau H
    Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.
    Walmod PS; Foley A; Berezin A; Ellerbeck U; Nau H; Bock E; Berezin V
    Cell Motil Cytoskeleton; 1998; 40(3):220-37. PubMed ID: 9678666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.
    Lin YL; Bialer M; Cabrera RM; Finnell RH; Wlodarczyk BJ
    Birth Defects Res; 2019 Aug; 111(14):1013-1023. PubMed ID: 30325584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teratology study of amide derivatives of branched aliphatic carboxylic acids with 4-aminobenzensulfonamide in NMRI mice.
    Onishi Y; Okada A; Noyori H; Okamura A; Hen N; Yagen B; Bialer M; Fujiwara M
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):318-27. PubMed ID: 24039104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-fluoro-2,2,3,3-tetramethylcyclopropanecarboxamide, a novel potent anticonvulsant derivative of a cyclic analogue of valproic acid.
    Pessah N; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
    J Med Chem; 2009 Apr; 52(8):2233-42. PubMed ID: 19296679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacodynamic and pharmacokinetic analysis of two anticonvulsant halo derivatives of 2,2,3,3-tetramethylcyclopropanecarboxamide, an amide of a cyclic analog of valproic acid.
    Pessah N; Kaufmann D; Yagen B; Hen N; Wlodarczyk B; Finnell RH; Bialer M
    Epilepsia; 2010 Oct; 51(10):1944-53. PubMed ID: 20738383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide.
    Sobol E; Yagen B; Lamb JG; White HS; Wlodarczyk BJ; Finnell RH; Bialer M
    Epilepsy Res; 2007 Jan; 73(1):75-84. PubMed ID: 16997532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarray analysis of homocysteine-responsive genes in cardiac neural crest cells in vitro.
    Rosenquist TH; Bennett GD; Brauer PR; Stewart ML; Chaudoin TR; Finnell RH
    Dev Dyn; 2007 Apr; 236(4):1044-54. PubMed ID: 17326132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproic acid teratogenicity: a toxicogenomics approach.
    Kultima K; Nyström AM; Scholz B; Gustafson AL; Dencker L; Stigson M
    Environ Health Perspect; 2004 Aug; 112(12):1225-35. PubMed ID: 15345369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascorbic acid reverses valproic acid-induced inhibition of hoxa2 and maintains glutathione homeostasis in mouse embryos in culture.
    Zhang B; Wang X; Nazarali AJ
    Cell Mol Neurobiol; 2010 Jan; 30(1):137-48. PubMed ID: 19655241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid-induced gene expression responses in rat whole embryo culture and comparison across in vitro developmental and non-developmental models.
    Tonk EC; Robinson JF; Verhoef A; Theunissen PT; Pennings JL; Piersma AH
    Reprod Toxicol; 2013 Nov; 41():57-66. PubMed ID: 23811354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model.
    Hsieh CL; Chen KC; Ding CY; Tsai WJ; Wu JF; Peng CC
    Rom J Morphol Embryol; 2013; 54(4):993-1004. PubMed ID: 24398995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of nitric oxide synthesis enhances teratogenic effects induced by valproic Acid.
    Tiboni GM; Chiarelli F; Verrotti A
    In Vivo; 2013; 27(4):513-8. PubMed ID: 23812222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproic acid and CEBPalpha-mediated regulation of adipokine gene expression in hypothalamic neurons and 3T3-L1 adipocytes.
    Brown R; Imran SA; Ur E; Wilkinson M
    Neuroendocrinology; 2008; 88(1):25-34. PubMed ID: 18212493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
    Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.